日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Novel Inhibitors for MDM2-MDM4 E3 Ligase Potently Induce p53-Indepedent Apoptosis in Drug-Resistant Leukemic Cells.

新型 MDM2-MDM4 E3 连接酶抑制剂可有效诱导耐药白血病细胞发生 p53 非依赖性凋亡

Lama Rati, Fose Joseph M, Martín Diana, Muñoz Inés G, Wang Eunice S, Sung Pamela J, Chemler Sherry R, Wang Xinjiang

Small-molecule MMRi36 induces apoptosis in p53-mutant lymphomas by targeting MDM2/MDM4/XIAP for degradation.

小分子 MMRi36 通过靶向 MDM2/MDM4/XIAP 进行降解,诱导 p53 突变淋巴瘤细胞凋亡

Lama Rati, Wu Wenjie, Mavis Cory K, Ruiz Federico M, Querol-García Javier, Martin Diana, Chemler Sherry R, Chandra Dhyan, Goodrich David W, Hernandez-Ilizaliturri Francisco J, Muñoz Inés G, Wang Xinjiang

Small molecule MMRi62 targets MDM4 for degradation and induces leukemic cell apoptosis regardless of p53 status

小分子MMRi62靶向MDM4使其降解,并诱导白血病细胞凋亡,且该作用不受p53状态的影响。

Lama, Rati; Xu, Chao; Galster, Samuel L; Querol-García, Javier; Portwood, Scott; Mavis, Cory K; Ruiz, Federico M; Martin, Diana; Wu, Jin; Giorgi, Marianna C; Bargonetti, Jill; Wang, Eunice S; Hernandez-Ilizaliturri, Francisco J; Koudelka, Gerald B; Chemler, Sherry R; Muñoz, Inés G; Wang, Xinjiang

HMBA is a putative HSP70 activator stimulating HEXIM1 expression that is down-regulated by estrogen

HMBA 是一种推定的 HSP70 激活剂,可刺激 HEXIM1 的表达,而雌激素会下调 HEXIM1 的表达。

Lama, Rati; Gan, Chunfang; Idippily, Nethrie; Bobba, Viharika; Danielpour, David; Montano, Monica; Su, Bin

Orally Active and Selective Tubulin Inhibitors as Anti-Trypanosome Agents

口服活性选择性微管蛋白抑制剂作为抗锥虫药物

Nanavaty, Vishal; Lama, Rati; Sandhu, Ranjodh; Zhong, Bo; Kulman, Daniel; Bobba, Viharika; Zhao, Anran; Li, Bibo; Su, Bin

Lead optimization of HMBA to develop potent HEXIM1 inducers

优化HMBA以开发强效HEXIM1诱导剂

Zhong, Bo; Lama, Rati; Ketchart, Wannarasmi; Montano, Monica M; Su, Bin

Identification of selective tubulin inhibitors as potential anti-trypanosomal agents

鉴定选择性微管蛋白抑制剂作为潜在的抗锥虫药物

Lama, Rati; Sandhu, Ranjodh; Zhong, Bo; Li, Bibo; Su, Bin